Literature DB >> 11885830

Selling drugs to doctors--it's marketing, not education.

Richelle Cooper1, Jerome Hoffman.   

Abstract

Keywords:  Health Care and Public Health

Mesh:

Year:  2002        PMID: 11885830      PMCID: PMC1314227     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  21 in total

1.  Reasons for not seeing drug representatives.

Authors:  D Griffith
Journal:  BMJ       Date:  1999-07-10

2.  The pharmaceutical industry--to whom is it accountable?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

3.  Trends in antihypertensive drug advertising, 1985-1996.

Authors:  T J Wang; J C Ausiello; R S Stafford
Journal:  Circulation       Date:  1999-04-20       Impact factor: 29.690

4.  Health-related quality-of-life claims in prescription drug advertisements.

Authors:  E A Rothermich; D S Pathak; D A Smeenk
Journal:  Am J Health Syst Pharm       Date:  1996-07-01       Impact factor: 2.637

5.  Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view.

Authors:  J F Beary
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

6.  Why would anyone have expected anything else? Characteristics of materials distributed by drug companies: four points of view.

Authors:  R Temple; P O'Brien
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

7.  Regulating pharmaceutical advertising: what will work?

Authors:  M F Shapiro
Journal:  CMAJ       Date:  1997-02-01       Impact factor: 8.262

8.  Whatalotwegot--the messages in drug advertisements.

Authors:  R E Ferner; D K Scott
Journal:  BMJ       Date:  1994 Dec 24-31

Review 9.  Characteristics of materials distributed by drug companies. An evaluation of appropriateness.

Authors:  D Stryer; L A Bero
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

Review 10.  Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.

Authors:  S D Findlay
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

View more
  1 in total

1.  Selling drugs to the public--should the UK follow the example of the US?

Authors:  John Frey
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.